BTARemoval from Official List |
09/11/12 | | 79.41KB | Share |
|
BTAMerger update, implementation of scheme of arrangement |
09/11/12 | | 112.9KB | Share |
|
BTABiota receives $4.2m R&D cash incentive |
07/11/12 | | 65.96KB | Share |
|
BTARelenza September Quarter Royalty |
01/11/12 | | 65.59KB | Share |
|
BTAInavir sales update |
31/10/12 | | 96.13KB | Share |
|
BTAAppendix 3Y - Change of Director's Interest Notice |
31/10/12 | | 69.76KB | Share |
|
BTAAppendix 3Y -Change of Director's Interest Notice |
31/10/12 | | 74.91KB | Share |
|
BTASuspension from Official Quotation |
30/10/12 | PRICE SENSITIVE | 101.45KB | Share |
|
BTAMerger update, lodgement of Court orders with ASIC |
30/10/12 | | 1.12MB | Share |
|
BTAChange in substantial holding |
30/10/12 | | 122.68KB | Share |
|
BTAAppendix 3B |
29/10/12 | | 131.94KB | Share |
|
BTASupreme Court of Victoria approves scheme of arrangement |
26/10/12 | PRICE SENSITIVE | 103.25KB | Share |
|
BTANabi to implement a share consolidation |
26/10/12 | | 101.71KB | Share |
|
BTAResults of Biota shareholder meeting |
23/10/12 | PRICE SENSITIVE | 184.3KB | Share |
|
BTABiota Holdings Limited - shareholder meeting |
23/10/12 | | 317.16KB | Share |
|
BTANabi shareholder meeting results |
23/10/12 | PRICE SENSITIVE | 102.13KB | Share |
|
BTAMerger update, determination of VWAP & share ratios |
19/10/12 | PRICE SENSITIVE | 65.17KB | Share |
|
BTAAppendix 3Y - Change of Director's interest Notice |
17/10/12 | | 33.26KB | Share |
|
BTAAppendix 3Y- Change of Director's Interest Notice |
03/10/12 | | 32.87KB | Share |
|
BTAAppendix 3Y - Change of Director's Interest Notice |
02/10/12 | | 70.05KB | Share |
|
BTAChange of Director's Interest Notice |
27/09/12 | | 33.35KB | Share |
|
BTAChange of Director's Interest Notice |
25/09/12 | | 69.6KB | Share |
|
BTARelease of Supplementary Explanatory Memorandum |
21/09/12 | | 930.28KB | Share |
|
BTAAnnual Report to shareholders |
21/09/12 | | 1.33MB | Share |
|
BTAAmended - Biota and Nabi announce Revised Merger Terms |
18/09/12 | | 961.9KB | Share |
|
BTABiota and Nabi announce Revised Merger Terms |
18/09/12 | PRICE SENSITIVE | 864.17KB | Share |
|
BTAUpdate in respect of CEO for Biota Pharmaceuticals |
07/09/12 | PRICE SENSITIVE | 91.25KB | Share |
|
BTAAppendix 3B |
24/08/12 | | 127.5KB | Share |
|
BTAAppendix 3B |
24/08/12 | | 129.33KB | Share |
|
BTAOpen Briefing - CEO on F12 results |
22/08/12 | PRICE SENSITIVE | 153.44KB | Share |
|
BTAPreliminary Final Report |
22/08/12 | PRICE SENSITIVE | 513.43KB | Share |
|
BTAInavir prevention study achieves primary endpoint |
22/08/12 | PRICE SENSITIVE | 93.67KB | Share |
|
BTAOpen Briefing - CEO on Nabi Merger |
20/08/12 | PRICE SENSITIVE | 186.55KB | Share |
|
BTARelease of Scheme Booklet |
10/08/12 | | 3.65MB | Share |
|
BTABiota Shareholders meeting on proposed merger with Nabi |
09/08/12 | | 91.93KB | Share |
|
BTAInavir June Quarter (Q4) Royalty |
31/07/12 | PRICE SENSITIVE | 80.37KB | Share |
|
BTARoyalties from Relenza for Q4 and F2012 |
26/07/12 | PRICE SENSITIVE | 80.18KB | Share |
|
BTAShareholder Update |
23/07/12 | PRICE SENSITIVE | 54.79KB | Share |
|
BTAChange in substantial holding |
06/06/12 | | 153.06KB | Share |
|
BTAChange of Director's Interest Notice |
22/05/12 | | 116.78KB | Share |
|
BTAAppendix 3B |
22/05/12 | | 127.22KB | Share |
|
BTAShareholder Update |
21/05/12 | PRICE SENSITIVE | 80.85KB | Share |
|
BTAFinancial update - resubmission |
16/05/12 | | 203.17KB | Share |
|
BTAFinancial update |
16/05/12 | PRICE SENSITIVE | 191.89KB | Share |
|
BTAInavir March Quarter (Q3) Royalty |
11/05/12 | PRICE SENSITIVE | 80.2KB | Share |
|
BTAInavir Phase III prevention study update |
11/05/12 | | 95.11KB | Share |
|
BTAAppendix 3B |
02/05/12 | | 127.33KB | Share |
|
BTAAppendix 3B |
26/04/12 | | 127.11KB | Share |
|
BTARelenza March Quarter Royalty |
26/04/12 | PRICE SENSITIVE | 73.77KB | Share |
|
BTABiota and Nabi Announce Proposed Merger |
23/04/12 | PRICE SENSITIVE | 907.07KB | Share |
|
BTAHRV Phase IIb Study Achieves Primary Endpoint |
28/03/12 | PRICE SENSITIVE | 125.51KB | Share |
|
BTAAppendix 3B |
28/03/12 | | 127.22KB | Share |
|
BTAResponse to an ASX price query |
21/03/12 | PRICE SENSITIVE | 214.16KB | Share |
|
BTAAppendix 3B |
09/03/12 | | 124.38KB | Share |
|
BTAOpen Briefing - CEO on 1H Results and Outlook |
15/02/12 | PRICE SENSITIVE | 222.75KB | Share |
|
BTAHalf Yearly Report and Accounts |
15/02/12 | PRICE SENSITIVE | 803.02KB | Share |
|
BTAInavir Phase III prevention study detail |
13/02/12 | PRICE SENSITIVE | 74.77KB | Share |
|
BTARelenza December Quarterly Royalty |
08/02/12 | PRICE SENSITIVE | 74.25KB | Share |
|
BTAInavir Q2 royalties |
31/01/12 | PRICE SENSITIVE | 73.67KB | Share |
|
BTAAppendix 3B |
22/12/11 | | 124.54KB | Share |
|
BTAChange in substantial holding |
21/12/11 | | 108.42KB | Share |
|
BTA2011 Annual General Meeting Results |
29/11/11 | | 111.31KB | Share |
|
BTA2011 AGM Addresses |
29/11/11 | | 733.69KB | Share |
|
BTAChange in substantial holding |
08/11/11 | | 101.01KB | Share |
|
BTAInavir sales update |
31/10/11 | PRICE SENSITIVE | 72.7KB | Share |
|
BTARelenza September Quarter Royalty |
27/10/11 | PRICE SENSITIVE | 73.68KB | Share |
|
BTANotice of Annual General Meeting/Proxy Form |
21/10/11 | | 429.95KB | Share |
|
BTAChange in substantial holding |
04/10/11 | | 108.89KB | Share |
|
BTAAnnual Report to shareholders |
29/09/11 | | 1.52MB | Share |
|
BTAAppendix 3B |
16/09/11 | | 124.21KB | Share |
|
BTAOpen Briefing - CEO on F11 results, BARDA Contract |
18/08/11 | | 190.11KB | Share |
|
BTAAppendix 3B |
18/08/11 | | 130.25KB | Share |
|
BTAPreliminary Final Report |
17/08/11 | PRICE SENSITIVE | 187.07KB | Share |
|
BTA Change in substantial holding from HHL |
09/08/11 | | 257.51KB | Share |
|
BTADr John Domagala joins Scientific Advisory Board |
03/08/11 | | 45.74KB | Share |
|
BTARoyalties from Inavir for Q4 and F2011 |
29/07/11 | PRICE SENSITIVE | 37.49KB | Share |
|
BTARoyalties from Relenza for Q4 and F2011 |
27/07/11 | PRICE SENSITIVE | 37.72KB | Share |
|
BTAChange in substantial holding |
18/07/11 | | 113.22KB | Share |
|
BTAPhase III prophylaxis trial for CS-8958 |
27/06/11 | PRICE SENSITIVE | 55.38KB | Share |
|
BTAChange in substantial holding |
15/06/11 | | 147.72KB | Share |
|
BTABiota obtains US$2.9m NIH grant for novel antibacterial |
10/06/11 | PRICE SENSITIVE | 45.78KB | Share |
|
BTAInavir Royalty for March 2011 quarter |
12/05/11 | PRICE SENSITIVE | 37.69KB | Share |
|
BTARelenza Royalty for March 2011 quarter |
28/04/11 | PRICE SENSITIVE | 35.12KB | Share |
|
BTAChange in substantial holding |
06/04/11 | | 160.33KB | Share |
|
BTABARDA awards major contract to Biota |
01/04/11 | PRICE SENSITIVE | 92.18KB | Share |
|
BTABiota appoints Piper Jaffray as financial advisor |
28/03/11 | | 49.6KB | Share |
|
BTAChange of Director's Interest Notice |
02/03/11 | | 116.63KB | Share |
|
BTAAppendix 3B |
02/03/11 | | 130.62KB | Share |
|
BTAChange of Director's Interest Notice |
23/02/11 | | 68.56KB | Share |
|
BTAOpen Briefing - CEO on Outlook, LANI Potential |
16/02/11 | PRICE SENSITIVE | 189.25KB | Share |
|
BTAHalf Year Report and Accounts |
16/02/11 | PRICE SENSITIVE | 1.29MB | Share |
|
BTARelenza Royalty for December 2010 quarter |
04/02/11 | PRICE SENSITIVE | 35.18KB | Share |
|
BTAInavir Royalty for December 2010 quarter |
01/02/11 | PRICE SENSITIVE | 37.39KB | Share |
|
BTAIV zanamivir - Phase III study commences |
20/01/11 | | 53.46KB | Share |
|
BTAResponse to ASX Price Query |
10/01/11 | PRICE SENSITIVE | 115.43KB | Share |
|
BTAAppendix 3B - New issue announcement |
23/12/10 | | 49.73KB | Share |
|
BTASecurities Trading Policy |
23/12/10 | | 234.92KB | Share |
|
BTA Change in substantial holding from HHL |
16/12/10 | | 719.44KB | Share |
|
BTABecoming a substantial holder |
08/12/10 | | 60.57KB | Share |
|
AAX SandP Announces December SP/ASX Rebalance |
03/12/10 | | 31.14KB | Share |